ThermoSafe Expands U.S. Vacuum Insulated Panel Production to Address Supply Chain Risks

ThermoSafe has increased its domestic production capacity for vacuum insulated panel (VIP) packaging in the United States. The company initiated this expansion to address rising demand for biologics and to mitigate supply chain risks associated with sourcing cold chain packaging materials from overseas.

The company’s decision follows a period of increased market pressure on the pharmaceutical logistics sector. By shifting more manufacturing operations to the U.S., ThermoSafe aims to shorten lead times and provide a more localized supply of temperature-controlled shipping solutions. This move aligns with broader industry trends as pharmaceutical companies seek to secure their cold chain infrastructure against international shipping disruptions and the growing volume of temperature-sensitive medical products requiring specialized transport.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

Author

GOAI